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21 INTRODUCTION
Multiple-outcome regression models pool information across related outcome variables; this
leads to higher power to detect a signiﬁcant exposure effect than ﬁtting separate regression models
(Thurston, Ruppert and Davidson 2009). Such joint models are popular, for instance, in epidemi-
ological studies, which often have multiple measures of physiological or psychological health and
attempt to detect small but important effects of low-dose exposure on those outcomes. In such
contexts it is crucial to use the available information as efﬁciently as possible.
There are two general approaches to modeling the effect of an exposure variable on multiple
correlated outcomes. One approach models the exposure effect on the outcomes directly (Sammel,
Lin, and Ryan 1999; Lin et al. 2000; Coull, Hobert, Ryan, and Holmes 2001; Roy, Lin, and
Ryan 2003; Thurston et al. 2009) and induces correlations between outcomes with random effects.
Another approach, called the continuous latent factor approach, introduces one or more continuous
latent variables that are manifested by the multiple outcomes (Dunson 2000; Budtz-Jorgensen,
Keiding, Grandjean and Weihe 2002; Muthe´n 2002; Budtz-Jorgensen, Keiding, Grandjean, Weihe
and White 2003; Sanchez, Budtz-Jorgensen, Ryan and Hu 2005). The direct modeling approach
includes the case where the outcomes are nested in domains (Thurston et al. 2009). This is a
common situation in epidemiology studies, where one is interested in the effect of exposure on a
set of outcomes within domains such as motor function, intelligence, and attention.
We show that the random effect model of Thurston et al. (2009) for multiple outcomes nested
in domains is a special case of the continuous latent factor model framework given in Sanchez
et al. (2005). This is not surprising since the latter is extremely general, and non-identiﬁable in the
unrestricted case. However, expressing the model of Thurston et al. (2009) in this way suggests
extensions and allows us to view the options for modeling grouped outcomes as a spectrum be-
tween parsimonious, but less ﬂexible, random effect models and highly parameterized, but more
ﬂexible, latent factor models. We introduce a set of models along this spectrum and show that they
are identiﬁable (Section 2). We characterize the tradeoffs between parsimony and ﬂexibility in
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exposure to infant anthropometry (Section 4).
Phthalates are synthetic chemicals that have been found to have toxic effects on developing
endocrine, immune, and reproductive systems in animal studies. In human male infants, prenatal
exposure has been linked to reduced anogenital distance, a sexually dimorphic trait, and postnatal
breast milk exposure has been associated with altered reproductive hormone concentration (Swan
et al. 2005; Sathyanarayana, Calafat, Liu, and Swan 2008). There is a great deal of interest in
whether phthalate exposure is associated with changes in other sexually dimorphic features in
infants, such as head circumference, weight, and measures of body fatness like skinfold thickness.
We analyze data from the Study for Future Families (Swan et al. 2003) to address this question.
While separate regression models ﬁt to the different outcomes have not detected a signiﬁcant link
to phthalate exposure, multiple-outcomes models like the ones we address here pool information
across related outcomes and thus have a better ability to detect such relationships; we investigate
the possibility of a phthalate effect using these models.
Both the simulation study and the phthalates analysis give evidence in support of using the most
general model out of those that we introduce. In the simulation study it has excellent accuracy in
point estimation of the outcome-speciﬁc exposure and covariate effects and acceptable accuracy in
estimation of the remaining parameters, regardless of which model we use to simulate the data. We
do ﬁnd additional improvement in accuracy associated with using one of our more parsimonious
models when the data are drawn from that model. We also ﬁnd a loss of accuracy for the outcome-
speciﬁc effects associated with using more parsimonious models when the data are drawn from
a more general model. Even so, all models we examined in the simulation study estimated these
effects with low error, even when the data were simulated under another model.
For the phthalates data, we do not ﬁnd a signiﬁcant effect of phthalate exposure on any of the
outcomes, so we use the covariate effects to illustrate the differences between the models. The
point estimates show differing degrees of shrinkage for the different models. Interestingly, for this
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but the simplest model. This is despite the fact that the interval estimates are wider in the most
general model. So in this dataset we do not see low power to detect covariate effects in the most
general model, again supporting its use.
2 MODELING GROUPED OUTCOMES
First we describe the random effect model of Thurston et al. (2009) for multiple outcomes
nested in domains, and show that it is a type of continuous latent factor model in the sense of
Sanchez et al. (2005), with one factor for each domain. The continuous latent factor model is
itself a special case of a structural equation model (SEM: cf. Sanchez et al. 2005). So we traverse
a spectrum from parsimony to ﬂexibility as we go from random effect models to latent variable
models to SEMs, and the model-choice decision is not between a SEM and a random effect model,
but rather about the appropriate amount of parsimony when considering model restrictions within
the SEM framework.
Denote the outcome measurements by Yi j for subjects i = 1, . . . ,n and outcomes j = 1, . . . , p.
Although we focus on the case of continuous outcomes, one can handle the discrete case by
use of the generalized linear model framework. The outcomes are grouped into domains d( j) ∈
{1, . . . ,d}, which are deﬁned to contain strongly positively correlated outcomes. Denote the co-
variates by the length-r vector Zi, and the (observed) exposure by ηi. In accordance with the
epidemiology literature we distinguish notationally between these two sets of predictors, although
they will be modeled in identical fashion; one can also drop ηi in the following models in order to
obtain a single undifferentiated set of predictors that includes exposure.
The model of Thurston et al. (2009) extends the linear mixed model approach to borrow infor-
mation across outcomes and domains while estimating the exposure effect. It provides shrinkage
of this effect across domains and across outcomes within a domain, and has higher power to detect
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variables, exposure, and all covariates are assumed to be standardized, and where the notation ind∼
indicates that the random effects are independently distributed.
Yi j = (bη +bD,η ,d( j) +bo,η , j)ηi +(bz +bD,z,d( j) +bo,z, j)Zi +qi +qi,d( j) + ei j (2.1)
where bη is a common exposure effect, bD,η ,k
ind∼ N(0,τ2D ) for k = 1, . . . ,d is a domain-speciﬁc
exposure effect, bo,η , j
ind∼ N(0,τ2o ) is an outcome-speciﬁc exposure effect, bz is a vector of overall
covariate effects, bD,z,k,
ind∼ N(0,τ2
D,) is a domain-speciﬁc covariate effect for the th covariate,
bo,z, j,
ind∼ N(0,τ2o,) is an outcome-speciﬁc covariate effect for the th covariate, qi
ind∼ N(0,τ2q ) is a
subject-speciﬁc random effect, qi,k
ind∼N(0,τ2q,k) is a subject-domain effect, and ei j
ind∼N(0,σ2j ) is the
residual error. The subject random effect qi captures the situation where all outcome measures are
positively correlated even after accounting for covariates and exposure. The subject-domain effect
qi,k captures additional correlation between outcomes within a domain. No intercept parameters
are included by Thurston et al. (2009) in model (2.1) due to centering of outcomes, exposure,
and all covariates. The class of models proposed by Thurston et al. (2009) allows the domain-
speciﬁc exposure and covariate effects, bD,η ,d( j) and bD,z,d( j), to be treated either as random effects
as in (2.1) or as ﬁxed effects.
In contrast with (2.1), a continuous latent factor model induces correlation between related
outcomes by assuming that they are all manifestations of a set of common unmeasurable (latent)
variables. The general form of a continuous latent factor (CLF) model is the following (Sammel
and Ryan 1996; Muthe´n 2002; Sanchez et al. 2005), where we take the number of factors equal to
the number of domains:
Yi = α +β o,ηηi +β o,zZi +Λξ i + ε i
ξ i = β D,ηηi +β D,zZi +Bξ i +ζ i. (2.2)
Here, Yi is the length-p vector of outcomes for the ith subject, α is a length-p vector of intercepts,
β o,η and β o,z are p×1 and p× r matrices of regression coefﬁcients, Λ is a p×d matrix of factor
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such that εi j
ind∼ N(0,σ2j ), β D,η and β D,z are d×1 and d× r matrices of regression coefﬁcients, ζ i
is a length-d vector such that ζi,k
ind∼ N(0,τ2ζ ,k), and B is a d×d matrix with zero diagonal elements
and (I−B) invertible. Without further restrictions this model is non-identiﬁable.
To see that (2.1) is a special case of (2.2), specify the factor loadings matrix Λ so that the latent
traits ξ i correspond to the outcome domains. To do this, the nonzero elements of Λ should be the
elements ( j,d( j)) for each j, which we call λ j. For example, if there are two domains and four
outcomes with d(1) = d(2) = 1 and d(3) = d(4) = 2 then
Λ =
⎛
⎝ λ1 λ2 0 0
0 0 λ3 λ4
⎞
⎠
T
.
For identiﬁability, it is common practice in factor analysis to set λ j = 1 for the ﬁrst outcome
measurement j in each domain (Sanchez et al. 2005).
Next, a parsimonious way to induce B is to take the second line of (2.2) to be ξ i = β D,ηηi +
β D,zZi + φi +ψ i, where φi
ind∼ N(0,τ2φ ) is a scalar and ψ i is a length-d vector such that ψik ind∼
N(0,τ2ψ,k). This is shown in Appendix A to be a special case of (2.2). Using these speciﬁcations,
Yi j = α j +βo,η , jηi +β o,z, jZi +λ jξi,d( j) + εi j i = 1, . . . ,n; j = 1, . . . , p
ξik = βD,η ,kηi +β D,z,kZi +φi +ψik k = 1, . . . ,d (2.3)
where β o,z, j and β D,z,k are the jth and kth rows of the matrices β o,z and β D,z, respectively. Apply
one more simpliﬁcation, setting λ j = 1 for all j which yields
Yi j = α j +(βD,η ,d( j) +βo,η , j)ηi +(β D,z,d( j) +β o,z, j)Zi +φi +ψi,d( j) + εi j. (2.4)
To obtain (2.1) drop the intercept term α j and use the random effect speciﬁcation βD,η ,k
ind∼N(bη ,τ2D ),
βD,z,k,
ind∼ N(bz,,τ2D,) βo,η , j
ind∼ N(0,τ2o ), and βo,z, j, ind∼ N(0,τ2o,) for each k, j and , after standard-
izing the outcome variables, the covariates, and the exposure.
We will investigate models that ﬁt into the framework (2.3), using the random effect assump-
tion that βo,η , j
ind∼ N(0,τ2o ) and βo,z, j, ind∼ N(0,τ2o,) and taking λ j = 1 for the ﬁrst outcome in each
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model (2.3) we have made assumptions regarding the structure of the matrices Λ and B; contrast
these choices with those standard in the SEM literature, where it is conventional to assign the la-
tent factors particular interpretations, such as “motor function” and “verbally mediated function.”
Having done that, one manually selects a small number of nonzero elements in the matrices B
and Λ corresponding to hypothesized associations among the interpreted factors and between the
interpreted factors and the individual outcome variables (Sanchez et al. 2005; Palomo, Dunson and
Bollen 2007). For instance, Palomo et al. (2007) have a set of four measurements of democra-
tization, measured separately for each country in 1960 and 1965. The four measurements from
1960 are taken to be indirect measurements of a latent factor capturing overall democratization
in 1960, and similarly for 1965. Due to the temporal relationship, they assume that the latent
democratization in 1960 had an effect on that in 1965 but not the other way around.
Like these authors, we associate each latent factor with a domain, and assign each of the out-
comes to a single domain. However, we avoid manually specifying the relationships between
the latent factors, instead making the assumption that the latent factors are related to each other
by inclusion of the subject random effect φi, and potentially by random effect modeling of the
domain-speciﬁc coefﬁcients βD,η ,k and βD,z,k,.
The subject random effect φi captures positive correlation between all of the outcomes, after
accounting for the exposure and covariates; to enforce this we restrict λ j > 0 for each j. This is
appropriate in many contexts, for instance the phthalates context of Section 4, the democratization
example of Palomo et al. (2007), and the study by Thurston et al. (2009) of the effect of prena-
tal methylmercury exposure on neurodevelopmental outcomes. In the case where not all of the
outcomes are positively correlated it may be possible to multiply some of the outcomes by −1 so
that our models can be applied; for instance, in the methylmercury analysis of Budtz-Jorgensen
et al. (2003), for most of the outcome variables a higher value indicates better neurological de-
velopment, but in a few it indicates worse development. After multiplying the latter outcomes
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correlated even after accounting for covariates and methylmercury exposure.
One could potentially also allow the case λ j = 0 in addition to λ j > 0. However, allowing
λ j = 0 simultaneously for all j leads to non-identiﬁability (see Section 2.1). Additionally, it seems
reasonable to require the latent factor associated with a domain to inﬂuence all of the outcomes
within that domain. For these reasons we restrict λ j > 0.
2.1 A SPECTRUM OF MODELS
Next we deﬁne a set of models for grouped outcomes that span the spectrum from ﬂexible latent
factor models to parsimonious random effect models, and show conditions for identiﬁability. All
variables are standardized before model-ﬁtting.
Model A: Given in (2.3), treating βD,η ,k, β D,z,k, α j, and λ j as ﬁxed effects restricting to λ j >
0, and recalling that λ j = 1 for the ﬁrst outcome in each domain and that βo,η , j ∼ N(0,τ2o ),
βo,z, j, ∼ N(0,τ2o,), φi ∼ N(0,τ2φ ), and ψik ∼ N(0,τ2ψ,k) are random effects.
Model B: Identical to Model A except that it models βD,η ,k as a random effect, βD,η ,k ∼
N(bη ,τ2D ) (reducing the effective number of free parameters in the model). Since this induces
shrinkage of βD,η ,k across domains k, it is only reasonable if the effect of ηi is believed to be
similar for the outcomes in all domains.
Model C: Identical to Model A except that it sets β o,η = β o,z = 0.
Model D: Identical to Model C except that it additionally sets λ j = 1 for every j.
Model E: Identical to Model D except that it additionally sets ψi,k = φi = 0 for each i and k,
yielding the most parsimonious model:
Yi j = α j +βD,η ,d( j)ηi +β D,z,d( j)Zi + εi j.
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within the same domain. It can be ﬁt independently for each domain. Models A-E all include
intercept terms α j (unlike (2.1)), despite the fact that all variables are standardized. Dropping the
intercept term would ignore the uncertainty in that intercept when estimating the parameters of
interest, potentially leading to poor interval estimates.
Models A-D capture positive correlation between the outcomes, even after accounting for ex-
posure and covariates. Models A-C allow the exposure effect (βo,η , j +λ jβD,η ,d( j)) and covariate
effects (β o,z, j +λ jβ D,z,d( j)) to be different for outcomes within a domain. Model B allows shrink-
age of the exposure effect across domains. In Appendix B we prove that our most general model
(Model A) is identiﬁable so long as there is more than one domain and more than one outcome
in each domain. If a particular domain has only one outcome, we show that identiﬁability can be
achieved by setting βo,η , j = τ2ψ,d( j) = 0 = β o,z, j for that outcome j.
We will use Bayesian inference in the above models. All prior distributions not given in the
model descriptions are speciﬁed as follows. The parameters λ j, α j, βD,η ,k, and the elements of
the vector β D,z,k, are given prior distributions that are uniform on the real line, in the case of λ j
restricting to positive values as discussed previously. For the variance parameters σ2j , τ2o , τ2o,, τ
2
D ,
τ2φ , and τ
2
ψ,k, we use a uniform prior on the associated standard deviation (Gelman, Carlin, Stern
and Rubin 2004), with support on the interval from zero to two. This upper bound is reasonable:
none of the variance parameters is expected to be greater than one due to the standardization of the
outcomes, but we use a slightly higher upper bound since in some cases the likelihood can be high
near and just above one. To understand why variance parameters with high likelihood typically
have values ≤ 1, take the example of Model A, and consider an arbitrary outcome j. Then
Var(Yi j|α j,βo,η , j,β o,z, j,βD,η ,d( j),β D,z,d( j),ηi,Zi) = λ 2j τ2φ +λ 2j τ2ψ,d( j) +σ2j . (2.5)
For parameter vectors with high likelihood, the model typically explains some of the variability in
the outcome Yi j in the sense that the conditional variance in (2.5) is ≤ Var(Yi j). Due to standard-
ization of Yi j, we then have λ 2j τ2φ +λ
2
j τ2ψ,d( j) +σ
2
j ≤ 1 for each j. This implies that σ2j ≤ 1, and
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taking j to be the ﬁrst outcome in an arbitrary domain k yields λ j = 1 and thus τ2φ ,τ
2
ψ,k ≤ 1. Fi-
nally consider τ2o and τ2o,, the variance of the regression coefﬁcients βo,η , j and βo,z, j,. The values
(βo,η , j +λ jβD,η ,d( j)) are the correlations between ηi and Yi j (which cannot be bigger than one in
absolute value), so it is reasonable to expect the standard deviation τo of βo,η , j to be below one,
and similarly for τo,.
While the prior distributions for λ j, α j, βD,η ,k, and β D,z,k are nonintegrable, the posterior dis-
tributions for Models A-E are integrable (well-deﬁned). We assessed prior sensitivity for the vari-
ance parameters by changing the upper bounds on the standard deviations; the inferences reported
in Sections 3-4 were insensitive to increases in the upper bound and to moderate decreases in the
upper bound. Not surprisingly, decreasing the upper bound so far as to truncate the region of high
likelihood changed the parameter estimates in an undesirable way.
2.2 COMPUTATION
Inference in Models A-E is performed by Markov chain Monte Carlo. We verify convergence
of the Markov chain to the posterior distribution using the Gelman-Rubin diagnostic (checking
that the scale reduction factor is less than 1.2 for each parameter; Gelman and Rubin 1992), and
ensuring that the Monte Carlo standard error as estimated using consistent batch means is less
than 0.5% of each parameter’s point estimate (Flegal, Haran and Jones 2008). For the simulation
study we allow slightly higher Monte Carlo standard error, roughly 2%, to reduce computation
time since we analyze a large number of treatment combinations. Parameter point estimates are
taken to be the posterior mean, and (1− a) interval estimates for a ∈ (0,1) are given by the a/2
and (1− a/2) quantiles of the posterior distribution. For the variance parameters and λ j we ﬁnd
the posterior mean on the log scale and then exponentiate to obtain the point estimate, since the
posterior distributions of these parameters are right-skewed.
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3 SIMULATION STUDY
3.1 EXPERIMENTAL CONDITIONS
We performed a simulation study to compare the performance of the ﬁve models and the trade-
off between ﬂexibility and parsimony. We used one exposure ηi and one covariate Zi, which were
generated from a bivariate normal distribution with mean zero, variance one and covariance 0.2 and
then standardized. The value of Yi was then simulated according to the models, with the standard
deviation (conditional on ηi,Zi, and all model parameters) of each Yi j set to one, i.e. σ j = 1. The
outcomes were not standardized as described in Section 2, because they are already standardized
in expectation.
Our primary comparison in the simulation study was between Models A and B or A and D. In
additional results not reported here, the performance of Model C was generally in between those
of Models D and A, and was similar to A when parameters βo,η , j and βo,z, j were not too large. We
leave out Model E because it does not incorporate dependence across domains; however, Model E
is explored in Section 4.
In addition to varying the models used to simulate and ﬁt the data, we also varied six fac-
tors each with two levels: (a) sample size (n=500 or 250); (b) number of outcomes in each do-
main, either (4, 2, 1) or (4, 6, 3); (c) λ j values (all equal to 1, or some = 1); (d) β¯D,η , deﬁned
as 13∑
3
k=1βD,η ,k, either (0.05 or 0.15); (e) βD,η ,k − β¯D,η , either (-0.05, 0, 0.05) or (-0.1, 0, 0.1),
and (f) βD,z,k− β¯D,z, either (-0.05, 0, 0.05) or (-0.2, 0, 0.2) where β¯D,z is deﬁned as 13∑3k=1βD,z,k.
For simulations in which some λ j = 1, for the model with (4,2,1) outcomes we used λ j val-
ues of (1,1,0.5,0.5, 1,0.5, 1) and for the model with (4,6,3) outcomes, we used λ j values
of (1,1,0.5,0.5, 1,1,1,0.5,0.5,0.5, 1,0.5,0.5). For all models we used β¯D,z = 0.2, τφ = 0.2, and
τψ,k = 0.05 for k = 1,2,3. For Models A and B, the standard deviations τo and τo,1 of βo,η , j and
βo,z, j were set to 0.05.
For each treatment combination, 25 datasets were generated. Instead of performing a full
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factorial design we analyze a subset of treatment combinations, since a full factorial design requires
ﬁtting the models exponentially many times and since Markov chain methods require nontrivial
computational time. In all estimation models, the value of λ j for the ﬁrst outcome in each domain
was set to one as discussed in Section 2. Convergence was diagnosed as discussed in Section 2.2.
3.2 EVALUATION
We evaluated the bias and the root mean squared error (RMSE) for ten parameters of interest,
such as βo,η , j and σ2j . Since each model has multiple σ2j parameters, for instance, we averaged
the bias and RMSE across the multiple parameters in such cases. Table 1 shows results for a
variety of conditions when data are simulated and analyzed under Model A. Table 2 gives results
from a small number of conditions when Models A, B, or D are the true model and the data
are analyzed under the same or different models. The ﬁnal rows are for the outcome-speciﬁc
slopes βo,η , j +λ j βD,η ,d( j), labeled ‘OS η’, and βo,z, j +λ jβD,z,d( j), labeled ‘OS z’, which are the
parameters of primary interest. The bias of λ j is presented on the log scale because the distribution
of λ j estimates was very right-skewed (a few of the simulated datasets have several λ j estimates
greater than 10).
These tables show that the parameter biases and RMSE are small for most parameters, and in
particular for the parameters of interest OS η and OS z. These parameters are estimated with little
bias and low RMSE under all conditions. The true values of the parameters OS η in this simulation
study typically range from −.15 to .35, while the values of the OS z parameters range from −.1
to .5. By contrast the absolute bias for all these parameters is below .015 under all conditions in
the Tables, and the RMSE is always less than .08, almost an order of magnitude smaller than the
parameter range. The bias and RMSE are even smaller if we look only at the conditions having
the larger sample size n = 500 and for which the ﬁtted model is at least as general as the simulated
model (the latter eliminates Columns 3, 5, and 6 of Table 2). In these cases the absolute bias is less
than .008, and the RMSE is less than .05.
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As expected the smaller sample size n = 250 gives higher RMSE for OS η and OS z than
n = 500; compare Column 2 to Column 3 and Column 4 to Column 5 in Table 1. Also, the RMSE
for these parameters is higher when the simulation model is A and we ﬁt the simpler model D;
compare Column 2 to Column 3 and Column 4 to Column 6 in Table 2. This is not surprising
since the simulated values for OS η and OS z are different for outcomes in the same domain, and
Model D restricts these to have a common value within a domain. On the other hand, when the
simulated model is D the RMSE of OS η and OS z are smaller when ﬁtting Model D than when
ﬁtting Model A; compare Columns 9 and 10 in Table 2. This demonstrates the advantage of ﬁtting
a simpler model when that model is correct. Interestingly, we do not see this advantage when the
simulated model is B; compare Columns 7 and 8 in Table 2. In this case ﬁtting Model A gives
nearly the same bias and RMSE as ﬁtting Model B, for almost all the parameters including OS
η and OS z. In general the results from ﬁtting Model B are very similar to those from ﬁtting
Model A (see also Columns 4-5 of Table 2), and we do not ﬁnd an advantage to using Model B
over Model A.
Although the estimates of the outcome-speciﬁc effects (OS η) j = βo,η , j + λ j βD,η ,d( j) and
(OS z) j = βo,z, j + λ jβD,z,d( j) are very accurate under all experimental conditions, the estimates
of the individual components λ j and βD,η ,k, βD,z,k are sometimes less accurate. In particular, when
both simulating from and ﬁtting Model A, with (4,6,3) outcomes per domain and the smaller
sample size n = 250 (Columns 6-10 of Table 1), λ j is overestimated while βD,η ,k and βD,z,k are
underestimated. However, this is greatly alleviated by increasing the sample size; compare the last
column of Table 1 to the ﬁrst column of Table 2, which are identical treatment conditions except
that the latter has the larger sample size n = 500. The bias (×100) of logλ j drops from 111.56 to
16.52, and similarly for βD,η ,k and βD,z,k. So caution should be taken in interpreting the λ j estimates
when the sample size is small, but the estimates of the outcome-speciﬁc effects OS η and OS z are
reliable.
The residual standard deviations σ j are also estimated well under all conditions. The true value
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is σ j = 1, while the absolute bias and the RMSE are less than .02 and .08, respectively (Tables 1-
2). Not surprisingly the standard deviation τψ,k of the domain-speciﬁc random effects is estimated
less accurately when there are fewer outcomes within each domain; see Table 1. For all simulation
conditions τψ,k’s are biased upwards, and τφ is biased downwards. This means that more of the
individual variation between outcomes is attributed to the domain-speciﬁc effects than is actually
the case. However this bias is smaller in simulations with many outcomes and a larger sample size;
compare Table 1 to Table 2.
In summary, this simulation study evaluated the accuracy of point estimation. It showed that
the parameters of most interest, the outcome-speciﬁc exposure and covariate effects, are estimated
well under all models and simulation conditions. They are estimated even more accurately when
restricting to the larger sample size, and when the ﬁtted model is at least as general as the sim-
ulation model. We do not ﬁnd an advantage to ﬁtting Model B over Model A under any of the
experimental conditions. Also, there is a deleterious effect of ﬁtting the simpler Model D when
the data come from Model A, in terms of accuracy of the outcome-speciﬁc effect estimates. When
Model D is the truth, there is an additional improvement in accuracy obtained by ﬁtting Model D,
but the estimates from Model A are still very accurate. Due to these facts, this simulation study
suggests that Model A is an excellent general-purpose choice from the perspective of accurate
point estimation, and that Model D has even better statistical efﬁciency if the data do indeed come
from such a parsimonious model. In addition to point estimation one should consider the width
of interval estimates and the power to detect exposure and covariate effects, which we explore in
Section 4.
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4 PHTHALATES ANALYSIS
4.1 DATA
Phthalates occur in a variety of industrial and household products including cosmetics, chil-
dren’s toys, and baby care products and use of some of these products has been linked to elevated
levels of phthalates in humans (Hauser and Calafat 2005; Sathyanarayana et al. 2008). The chem-
icals are believed to affect reproductive hormone concentration and anogenital distance in male
infants, via an anti-androgenic and possibly estrogenic mechanism (Gray et al. 2006). This leads
to the hypothesis that they may affect other sexually dimorphic traits in male infants, including
anthropometric measures like head circumference, weight and skinfold thickness.
The Study for Future Families is a multicenter pregnancy cohort study relating maternal phtha-
late levels to a variety of infant anthropometric and reproductive characteristics (Swan et al. 2003).
The data include measurements of phthalate metabolite concentrations in maternal urine, infant
anthropometry measurements, and relevant covariate information for several hundred pregnancies.
Measurements of eight distinct phthalate metabolites are available, most of which are highly cor-
related. We will summarize these measurements and relate them to the anthopometry outcomes
via the phthalate “score.” This score (deﬁned in Swan 2008) is a summary of the ﬁve phthalate
measurements that have been found to be related to anogenital distance in male infants; this score
falls in the range (0− 15), with 15 representing the highest exposure. One can instead directly
use all the phthalate measurements by taking ηi to be a latent variable that represents overall ph-
thalate exposure, and adapting Models A-E to this context (in the manner of a structural equation
model). Explicitly, this approach assumes that ηi ∼ N(0,1) and models the multiple phthalate
measurements Xi indexed by  as Xi
ind∼ N(αX +λXηi,δ 2 ). Our results from this approach were
qualitatively very similar to those reported here.
The infant anthropometry measurements include four skinfold thickness metrics plus body
mass index, weight percentile-for-age, and head circumference percentile-for-age. Most of these
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traits are known to be strongly sexually dimorphic; in particular, skinfold thickness measures tend
to be larger in females at all ages up to three years, while head circumference and weight are larger
in males than females of the same age (Rodriguez et al. 2004; U.S. Centers for Disease Control and
Prevention 2000). The case of body mass index (BMI) is a bit more subtle, since although it tends
to be slightly larger in boys then girls at birth, this may change with age; additionally, BMI is not
typically used as a clinical measure of body fatness or composition in infants (Wells 2000; Brock,
Falcao and Leone 2008). We include it here for completeness. The anthropometry metrics fall into
three natural domains, namely (1) the skinfold thickness metrics, (2) weight percentile and BMI,
which are closely related, and (3) head circumference percentile. We address the hypothesis that,
due to an anti-androgenic mechanism, phthalates affect anthropometry measures in male infants,
causing these measures to be more like those of females. For the above outcomes that means higher
skinfold thickness, lower weight, and smaller head circumference.
Covariates are available including infant’s age and gestational age, mother’s age at time of
birth, mother’s race, mother’s educational level, mother’s smoking status, and the creatinine con-
centration for the urine sample from which the phthalate measurements were taken. We performed
a preliminary analysis by regressing each of the anthropometry measurements on the covariates
and phthalate score. In this and the rest of our regression analyses, we used the following transfor-
mations of the variables in order to make the assumptions of the linear models most reasonable: a
square root transformation of the skinfold thickness measurements and creatinine concentration; a
logistic transformation for the weight percentile and head circumference percentile, after rounding
the smallest measurements up to 0.001 and the largest down to .999; and a log transformation of the
phthalate score. After these transformations, all variables are standardized before ﬁtting regression
models, as described in Section 2.1.
Fitting the separate linear regression models for the anthropometry outcomes and applying
backward elimination, we found strong evidence of a relationship between infant’s age, gesta-
tional age, mother’s age, and mother’s race (categorizing into caucasian / non-) and some of the
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anthropometry measures. We include these four predictors in our models, as well as the creatinine
concentration. Although the latter was not found to be a signiﬁcant predictor for any of the anthro-
pometric outcomes, it is a signiﬁcant predictor for the phthalate concentrations and is included in
order to adjust for this effect (Barr et al. 2005). We restrict to infants for which complete data are
available for the phthalate and anthropometry measurements, age, gestational age, mother’s age,
mother’s race, and creatinine, leaving 118 male infants out of 172.
Table 3 gives summary statistics for the anthropometry metrics and covariates, and relates
these variables to the phthalate score. It shows the average phthalate score for individuals in each
category (for categorical variables) or individuals above and below the variable median (for con-
tinuous variables). It also shows the regression coefﬁcient for phthalate score obtained from the
separate regressions on standardized data described above, along with 95% conﬁdence intervals.
In Table 3 the phthalate score is empirically higher for Caucasian mothers, younger mothers, in
cases of younger infants or infants with a lower gestational age, and in cases with higher creatinine
concentrations. We do not see a signiﬁcant relationship between phthalate score and the outcome
variables using the separate regressions; the hope is that by ﬁtting the multiple-outcomes mod-
els from Section 2.1 we will have higher power to detect a phthalate effect if one exists. Some
but not all of the point estimates of the phthalate coefﬁcients in Table 3 are consistent with the
hypothesized effect.
4.2 RESULTS
Next we apply Models A, C, D, and E to the phthalates data. We omit Model B from consider-
ation because we do not hypothesize that the phthalate effect is similar across domains (e.g., it is
not hypothesized to have the same sign in all domains). The third domain deﬁned in Section 4.1
has only one outcome variable (head circumference), so for identiﬁability in Models A,C,D,E we
set βo,η , j = τ2ψ,d( j) = 0 = β o,z, j for this outcome j. To see whether Models A, C, and D were
appropriate we veriﬁed that the residuals from the separate regressions done in Section 4.1 were
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positively correlated for the different outcomes, which they were (having correlations .08− .65).
The estimates of the phthalate effects (OS η) j = (βo,η , j +λ jβD,η ,d( j)) for each of the outcome
variables j and each of the models A,C,D,E are shown in Table 4. While the point estimates are
similar for Models D and E, the posterior 95% intervals are wider for Model D, reﬂecting the fact
that Model E is more parsimonious. However, there is evidence that Model D ﬁts the data better:
the random effects φi and ψi,k, which are missing in Model E, have high variance in Model D
(the point and 95% interval estimates of τφ , τψ,1, and τψ,2 are .50 (.40, .61), .22 (.025, .41), and
.54 (.38, .70), respectively).
The width of the posterior intervals decreases from left to right in Table 4 as the parsimony of
the model increases; the average interval width in the Table is 47.4, 44.5, 38.9, and 27.1 for Models
A, C, D, and E respectively. Although Models A, C, D, and E are more parsimonious than separate
regression models, we still do not ﬁnd a signiﬁcant relationship between phthalate exposure and
the anthropometry outcomes in any of the models. While links have been found between phthalate
exposure and other sexually dimorphic traits, such a link may not exist between phthalate exposure
and the anthropometry measures investigated here. Alternatively, such a link may exist and we may
not be able to detect it due to the limited size of our dataset and the need to adjust for a number
of covariates, including the creatinine concentration and infant’s age. There is also some inﬂation
of the uncertainty in the phthalate score regression coefﬁcients, due to the correlation between
phthalate score and creatinine. In a standard multiple linear regression model the magnitude of
this effect could be measured using the variance inﬂation factor (Neter, Kutner, Nachtsheim and
Wasserman 1996). Although it is not obvious how to calculate a variance inﬂation factor for our
multiple-outcomes models, in a standard linear regression model with our set of covariates the
variance inﬂation factor for phthalate score would be 2.44, which is low, indicating that this effect
is not a source of concern.
Since we have not detected a phthalate effect using any of the models, we will demonstrate
the differences between Models A,C,D,E using differences in the covariate effects. The covariate
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effects (OS Z) j = β o,z, j +λ jβ D,z,d( j) for the simplest model, Model E, are shown in Table 5. In
this model the covariate effects are domain-speciﬁc but not outcome-speciﬁc ((OS Z) j simpliﬁes
to β D,z,d( j)), so we display them by domain. We ﬁnd a positive relationship between gestational
age and the BMI and weight percentile outcomes. This is in accordance with previous ﬁndings
of a positive correlation between gestational age and BMI/weight (U.S. Centers for Disease Con-
trol and Prevention, National Center for Health Statistics 2000). Some drawbacks of the CDC
weight-for-age growth chart in relation to the WHO growth charts have also been noted (de Onis,
Garza, Onyango and Borghi 2007). We also ﬁnd a negative relationship between mother’s age and
the skinfold thickness outcomes, which is plausible although previously unobserved. We ﬁnd a
negative relationship between infant age and the outcomes in domains one and two, namely the
skinfold thickness, BMI, and weight percentile outcomes. Such relationships are surprising, in part
since weight percentile is already adjusted for infant age. These negative correlations also exist in
the raw data; however, if we restrict to infants in the most rapid phase of growth (younger than 9
months) these become positive correlations, which are in accordance with previous ﬁndings.
The point estimates for the parameters (OS Z) j in Model D are nearly identical to those for
Model E as reported in Table 5 (on average differing by only 2.1%). However, the 95% intervals for
(OS Z) j are substantially wider in Model D than in Model E (wider on average by 46%). Because
of this, the effect of mother’s age in Domain 1 is not signiﬁcant in Model D. This illustrates the
fact that Model E is more parsimonious than Model D.
Models A and C allow the covariate effects (OS Z) j to be different for each outcome in a
domain, while Models D and E do not. For the phthalates data this model ﬂexibility comes with a
price in terms of the width of the 95% posterior intervals for (OS Z) j. The average width of these
intervals is 34.8, 27.5, 26.6, and 18.2 (strictly decreasing) for Models A, C, D, and E respectively.
However, Model C has the same number of signiﬁcant covariate effects (8 signiﬁcant effects) as
Model D for the phthalates data, and Model A has one more (9 effects). Model C has the same set
of signiﬁcant regression coefﬁcients as Model D, while Model A has a slightly different set. The
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following effects are signiﬁcant in Models C and D but not in Model A (listing covariate / outcome
pairs) : (1) infant age / skinfold thickness quadriceps; (2) infant age / BMI; (3) gestational age
/ BMI. The following effects are signiﬁcant in Model A but not in Model C: (1) mother’s age /
skinfold thickness quadriceps; (2) mother’s age / skinfold thickness triceps; (3) gestational age /
skinfold thickness triceps; (4) race / skinfold thickness subscapular.
Given the discrepancy between the conclusions that would be drawn from Models A and C,
we attempt to determine which model is more believable in the phthalates context. We do this by
ﬁnding evidence to corroborate the coefﬁcient point estimates from one of these two models. When
the point estimates from Model A are averaged over the outcomes in each domain, the results are
very close to the estimates of (OS Z) j from Models D and E (on average differing from Model D
by 3.1% and from Model E by 2.9%). However, when the same procedure is done for Model C, the
estimates differ substantially from Models D and E (on average differing from Model D by 47%
and from Model E by 46%).
We can additionally compare the results from Models A and C to the separate regressions that
were ﬁt to each outcome variable in Section 4.1. Since Models A and C ﬁt a joint model to all
of the outcome variables, we can expect the point estimates of (OS Z) j for outcomes in the same
domain to be shrunk towards each other, relative to the point estimates from separate regression
models. So we don’t expect the point estimates from Models A and C to be very close to those
from the separate regressions, but we might expect the point estimates averaged over a domain to
be similar between the separate regressions and Models A and C. Indeed, the point estimates from
from Model A, averaged over each domain, are very similar to those from the separate regressions
(differing on average by only 5.0%). However, the point estimates from Model C, averaged over
each domain, are very dissimilar to those from the separate regressions (differing on average by
62%). So we can ﬁnd little corroboration for the point estimates obtained by Model C, and ﬁnd
the results from Model A to be more believable.
The relationship of the estimated effects (OS Z) j from Models A, C, D, E, and those obtained
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from separate regressions are illustrated in Figure 1. Estimates from Model A show shrinkage
towards the domain average, relative to estimates from the separate regressions. Models D and
E restrict to a single coefﬁcient estimate per domain, and this estimate is close to the average of
the outcome-speciﬁc estimates from Model A and close to the average of the outcome-speciﬁc
estimates from separate regressions. By contrast, no shrinkage between domains is visible; this is
due to the fact that the domain-speciﬁc coefﬁcients β D,z,k are ﬁxed effects in these models. The
coefﬁcient estimates from Model C, shown at the bottom of Figure 1, are substantially different
from those of the other models.
The shrinkage of coefﬁcients in Model A relative to separate regressions appears moderate in
Figure 1. However, in cases where the signal-to-noise ratio is low this shrinkage can be dramatic.
For the phthalates data this can be seen by comparing Table 3, Column 4 to Table 4, Column
1. The coefﬁcient estimates are strongly pulled together. Due to the ability of Model A to pool
information across outcomes, it detects one more signiﬁcant covariate effect than do the separate
regression models (9 vs. 8), namely between the covariate “infant age” and the outcome “skinfold
thickness triceps.”
5 CONCLUSIONS
We introduced models for regression with multiple outcomes nested in domains, that span the
spectrum from very general continuous latent factor models to very parsimonious random effect
models. These extend the model of Thurston et al. (2009) in the sense that some of them allow
outcome-speciﬁc weights λ j for the latent factors associated with the domains. We evaluated these
models on simulated data and on the phthalates data. The simulation study found the most general
model, Model A, to be very accurate in terms of point estimation of the outcome-speciﬁc exposure
and covariate effects, regardless of which of the models is used to simulate the data. It also found
an additional advantage to ﬁtting the simpler Model D when the data are drawn from Model D, but
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no advantage to Model B under any of the experimental conditions. In the models that incorporate
the λ j parameters, they are sometimes estimated with substantial upward bias, but this effect is
alleviated by increasing the sample size, and the bias does not affect the accuracy for the outcome-
speciﬁc effects of interest.
In the phthalates analysis Model B was not appropriate and Models A, C, D, and E were con-
sidered. None of the models found a phthalate effect on any of the outcomes, so we focused on the
covariate effects to investigate the differences between the models. We found that Models A, D,
and E gave point estimates that were reasonable and consistent with one another, while those from
Model C were distinct and uncorroborated by other evidence. This suggests that it is disadvan-
tageous to incorporate the parameters λ j without also including outcome-speciﬁc random effects
βo,η , j and β o,z, j. While the interval estimates were wider in Model A than in Model D, a larger
number of signiﬁcant covariate effects were found in Model A. Model A has the advantage that it
is much more ﬂexible than the other models, and easier to justify since it allows the exposure and
covariate effects to differ across outcomes within a domain. Since there was no loss of the ability
to detect covariate effects relative to Model D, Model A is the most reasonable choice for the ph-
thalates data. Although Model E found more signiﬁcant covariate effects than any other model, it
is a very difﬁcult model to justify for the phthalates data. This is in part because it assumes condi-
tional independence of the outcomes given the covariates, exposure, and regression coefﬁcients, a
property which is clearly violated for these data.
In summary, we found that Models A and D performed better than the other three models for
both simulated and real data. Model A is much more ﬂexible than Model D in the sense of allowing
the exposure and covariate effects to differ for outcomes in the same domain, so we recommend this
model for general use. In some cases where the effects might plausibly be the same for outcomes
within each domain (after standardization), and where statistical efﬁciency is of primary concern
due to a small sample size, Model D is also a good choice.
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Num of Outcomes 4,2,1 4,6,3
β¯D,η 0.05 0.05 0.15 0.15
sd(βD,η), sd(βD,z) Small Small Large Small Large Large
λ j Same Different Same Diff
n 250 500 250 500 250
bias σ j -1.39 -1.07 -1.99 -1.61 -0.46 -0.78 -0.38 -0.29 -0.68
bias τφ -4.80 -3.14 -8.40 -6.58 -7.74 -10.93 -10.30 -8.85 -13.15
bias τψ,k 8.68 6.49 11.60 10.38 3.52 3.25 1.92 2.21 4.12
bias log(λ j) -22.89 -20.63 8.14 -13.38 46.97 72.99 59.70 45.92 111.56
bias βo,η , j ×100 0.12 0.45 -0.12 0.47 0.02 0.56 0.78 0.78 0.16
bias βo,z, j 0.90 1.45 0.52 1.00 1.46 1.49 0.81 1.09 1.14
bias βD,η ,k 0.32 0.72 1.36 -0.29 -1.03 -0.32 -4.46 -2.72 -3.49
bias βD,z,k -0.49 -0.34 -1.18 -1.73 -4.07 -4.23 -5.74 -2.28 -4.64
bias OS η 0.30 0.51 0.84 0.26 -0.51 0.28 -0.88 -0.80 -0.34
bias OS z -1.23 -0.38 -0.50 -0.77 -0.56 -1.50 -1.09 0.10 -0.64
RMSE σ j 5.59 4.33 7.24 6.24 5.20 5.30 5.22 5.33 5.68
RMSE τφ 7.51 6.30 9.26 7.84 10.83 12.74 11.05 10.85 14.75
RMSE τψ,k 9.86 7.78 13.60 12.28 7.80 7.63 5.60 5.45 11.98
RMSE log(λ j) 44.48 42.59 52.28 46.63 92.68 115.16 83.94 80.39 141.57
RMSE βo,η , j ×100 3.87 4.02 3.72 3.76 4.23 4.70 4.90 4.57 4.74
RMSE βo,z, j 4.24 4.49 4.45 4.01 5.79 5.61 5.18 5.23 5.37
RMSE βD,η ,k 6.51 4.46 5.97 5.15 4.26 4.61 6.88 6.38 7.58
RMSE βD,z,k 5.58 4.67 7.24 5.70 8.79 9.05 8.47 7.39 9.53
RMSE OS η 5.56 4.10 5.19 3.77 5.02 5.07 5.19 5.27 5.74
RMSE OS z 5.81 4.16 5.71 4.39 6.03 5.52 5.84 5.55 5.62
Table 1. Values of bias×100 and RMSE×100, for some particular treatments in the simulation study.
In all of these cases, we use data simulated from Model A and we report the results for ﬁtting
Model A. Also, recall the true values of τo = τo,1 = 0.05, σ j = 1, τφ = 0.2, and τψ,k = 0.05.
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λ j Different Same
Simulated Model A Model A Model B Model D
Estimation A D A B D A B A D
bias σ j -0.36 0.68 -0.30 -0.30 0.15 -0.01 -0.00 -0.28 -0.09
bias τφ -7.03 -7.89 -3.91 -3.92 -1.44 -2.92 -3.13 -3.44 -1.41
bias τψ,k 4.08 1.27 2.66 2.64 2.73 3.25 2.99 2.75 2.84
bias log(λ j) 16.52 48.52 -0.10 -0.04 0.00 -3.06 -0.90 0.96 0.00
bias βo,η , j 0.21 -0.33 0.68 0.74 -0.03 0.39 0.42 0.17 0.00
bias βo,z, j ×100 0.96 0.43 0.44 0.45 -0.06 0.39 0.45 0.24 0.00
bias βD,η ,k -1.08 -4.12 -1.35 -1.69 -0.06 -0.22 -0.54 -0.80 -0.01
bias βD,z,k -2.18 -6.59 -0.61 -0.90 0.34 -0.40 -0.75 -1.49 -0.25
bias OS η -0.05 0.18 -0.52 -0.53 -0.28 0.07 0.04 -0.39 -0.13
bias OS z -0.01 0.16 -0.02 -0.02 0.16 -0.28 -0.28 -0.29 -0.09
RMSE σ j 3.36 3.40 3.40 3.39 3.31 3.48 3.49 3.53 3.35
RMSE τφ 8.70 8.26 5.01 4.98 2.37 4.10 4.27 4.64 2.01
RMSE τψ,k 7.58 2.43 4.72 4.62 4.72 5.41 5.03 5.92 4.93
RMSE log(λ j) 62.33 50.86 38.17 38.03 0.00 31.53 32.13 34.70 0.00
RMSE βo,η , j 4.07 4.64 4.45 4.52 5.16 4.30 4.32 1.25 0.00
RMSE βo,z, j ×100 4.37 4.93 4.51 4.51 4.97 4.65 4.71 1.83 0.00
RMSE βD,η ,k 5.36 6.31 3.88 4.07 3.60 3.89 3.92 3.30 2.55
RMSE βD,z,k 5.67 9.41 5.23 5.35 3.32 4.65 4.87 3.75 2.47
RMSE OS η 4.07 6.11 3.96 3.97 5.00 4.03 4.06 3.47 2.53
RMSE OS z 4.26 7.75 4.09 4.09 5.00 4.01 4.03 3.64 2.31
Table 2. Values of bias×100 and RMSE×100, for some particular treatments in the simulation study.
In all of these cases, we use 4, 6, and 3 outcomes in the three domains, a large sample
size (n = 500), the large exposure eﬀect (β¯D,η = 0.15), and large deviations between domains
(sd(βD,η) and sd(βD,z)). Also, recall the true values of τo = τo,1 = 0.05, σ j = 1, τφ = 0.2, and
τψ,k = 0.05.
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Variable Counts or Avg. Phthalate Score Regression
Mean ±SD (By Category or Coefﬁcient for
≤ / > Variable Median) Phthalate Score (×100)
Mother’s Race (Cauc. / Non-) 89 / 29 7.53 / 7.07 –
Mother’s Age 30.1±5.08 8.46 / 6.37 –
Infant Age (mos.) 10.3±7.30 8.02 / 6.81 –
Gestational Age (wks.) 39.0±2.18 7.55 / 7.19 –
Creatinine 88.5±62.1 4.29 / 10.54 –
Skinfold Thickness Flank 5.56±1.86 7.26 / 7.60 −13.5 (−40.3,13.3)
Skinfold Thickness Quadriceps 14.82±5.42 6.89 / 8.19 5.38 (−22.3,33.1)
Skinfold Thickness Subscapular 6.96±1.98 7.04 / 8.12 −3.29 (−28.2,21.6)
Skinfold Thickness Triceps 9.74±2.42 7.00 / 7.86 13.1 (−13.5,39.8)
Body Mass Index 16.8±1.49 6.90 / 7.95 7.76 (−20.7,36.2)
Weight Percentile 49.1±31.5 6.90 / 7.93 11.1 (−15.6,37.7)
Head Circumference Percentile 56.3±30.1 7.53 / 7.31 −1.26 (−29.4,26.9)
Table 3. Column 2: Summaries of the anthropometry measurements and covariates; Column 3: average
phthalate score for individuals in each category (for categorical variables) or individuals above
and below the variable median (for continuous variables); Column 4: regression coeﬃcient for
phthalate score, with 95% conﬁdence interval.
Model A Model C Model D Model E
ST Flank −3.32 (−27.6,19.8) −3.13 (−25.6,18.9) 0.345 (−19.0,19.9) 0.221 (−13.5,13.6)
ST Quadriceps −0.317 (−20.3,20.7) −2.01 (−17.5,13.6) 0.345 (−19.0,19.9) 0.221 (−13.5,13.6)
ST Subscapular −2.40 (−24.5,19.5) −3.27 (−27.0,20.2) 0.345 (−19.0,19.9) 0.221 (−13.5,13.6)
ST Triceps 1.03 (−16.3,20.0) −1.56 (−14.2,11.4) 0.345 (−19.0,19.9) 0.221 (−13.5,13.6)
BMI 9.47 (−15.0,34.0) 7.95 (−10.8,27.4) 9.86 (−14.5,33.4) 9.43 (−10.0,29.1)
Weight 9.52 (−15.2,34.8) 11.1 (−14.9,37.5) 9.86 (−14.5,33.4) 9.43 (−10.0,29.1)
Head Circum. −1.40 (−31.1,28.4) −1.27 (−30.7,28.5) −0.920 (−31.3,29.2) −1.34 (−30.5,26.9)
∗ ST: Skinfold Thickness
Table 4. Estimated phthalate exposure eﬀect (βo,η , j +λ jβD,η ,d( j)) times 100 for each of the outcome
variables j. 95% credible intervals are shown in parentheses.
Covariate Domain 1 Domain 2 Domain 3
Sqrt. Creatinine 1.32 (−12.2,14.7) 0.405 (−18.5,19.5) 5.88 (−22.4,34.5)
Infant Age −27.9 (−37.1,−18.9) −19.2 (−32.0,−6.36) 16.1 (−2.68,34.9)
Mother’s Age −11.6 (−21.0,−2.51) 0.133 (−13.2,13.4) 9.97 (−9.40,29.5)
Gestational Age 8.29 (−0.601,17.3) 17.5 (4.62,30.4) 10.4 (−8.27,29.1)
Race (0:Cauc., 1:Non-) 4.43 (−4.62,13.6) 4.56 (−8.10,17.3) −12.3 (−31.1,6.42)
Table 5. Estimated covariate eﬀects (β o,z, j +λ jβ D,z,d( j)) times 100 in Model E for the phthalates data.
95% credible intervals are shown in parentheses.
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Figure 1. Coefﬁcient estimates (×100) for Models A, C, D, and E and separate regressions, for two repre-
sentative predictors and the Domain 1 outcomes.
